Personalised Medicine (PerMed) opens unexplored frontiers to treat diseases at the individual level combining clinical and omics information. However, the performances of the current simu

AI4EU will efficiently build a comprehensive European AI-on-demand platform to lower barriers to innovation, to boost technology transfer and catalyse the growth o